Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking

Molecular and Cellular Biochemistry

Volumn 345, Issue 1-2, 2010, Pages 105-118

  Pierleoni, Raffaella ^a   Menotta, Michele ^a   Antonelli, Antonella ^a   Sfara, Carla ^a   Serafini, Giordano ^a   Dominici, Sabrina ^a   Laguardia, Maria Elena ^b   Salis, Annalisa ^c   Damonte, Gianluca ^c   Banci, Lucia ^d   Porcu, Marco ^d   Monini, Paolo ^e   Ensoli, Barbara ^e   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b Diatheva Srl ^*  (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cell internalization; HIV; Redox state; Tat

Indexed keywords

CYSTEINE; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL MIGRATION; DISULFIDE BOND; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; MACROPHAGE; OLIGOMERIZATION; OXIDATION REDUCTION STATE; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN TRANSPORT;

CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; DISULFIDES; ENDOCYTOSIS; GENE PRODUCTS, TAT; HUMANS; MACROPHAGES; MASS SPECTROMETRY; MODELS, MOLECULAR; OXIDATION-REDUCTION; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78449276214     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0564-9     Document Type: Article

References (45)

1. V Beral TA Peterman RL Berkelman HW Jaffe 1990 Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335 123 128 1:STN:280:DyaK3c7htlKhug%3D%3D 10.1016/0140-6736(90)90001-L 1967430
2. AM Levine 1992 Acquired immunodeficiency syndrome-related lymphoma Blood 80 8 20 1:STN:280:DyaK38zgsFemtQ%3D%3D 1319239
3. B Ensoli G Barillari SZ Salahuddin RC Gallo F Wong-Staal 1990 Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients Nature 345 84 86 1:CAS:528:DyaK3cXktVCntL8%3D 10.1038/345084a0 2184372
4. HC Chang F Samaniego BC Nair L Buonaguro B Ensoli 1997 HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region AIDS 11 1421 1431 1:CAS:528:DyaK2sXntVCksrw%3D 10.1097/00002030-199712000-00006 9342064
5. G Barillari L Buonaguro V Fiorelli J Hoffman F Michaels RC Gallo B Ensoli 1992 Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis J Immunol 149 3727 3734 1:CAS:528:DyaK3sXhtVSitbo%3D 1431144
6. B Ensoli L Buonaguro G Barillari V Fiorelli R Gendelman RA Morgan P Wingfield RC Gallo 1993 Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation J Virol 67 277 287 1:CAS:528:DyaK3sXlsl2qtg%3D%3D 8416373
7. A Cafaro A Caputo C Fracasso MT Maggiorella D Goletti S Baroncelli M Pace L Sernicola ML Koanga-Mogtomo M Betti A Borsetti R Belli L Akerblom F Corrias S Butto J Heeney P Verani F Titti B Ensoli 1999 Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine Nat Med 5 643 650 1:CAS:528:DyaK1MXjs1KmurY%3D 10.1038/9488 10371502
8. MC Re G Furlini M Vignoli E Ramazzotti G Roderigo V De Rosa G Zauli S Lolli S Capitani M La Placa 1995 Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo J Acquir Immune Defic Syndr Hum Retrovirol 10 408 416 1:CAS:528:DyaK28Xltlagug%3D%3D 10.1097/00042560-199512000-00003 7583436
9. I Tikhonov TJ Ruckwardt GS Hatfield CD Pauza 2003 Tat-neutralizing antibodies in vaccinated macaques J Virol 77 3157 3166 1:CAS:528: DC%2BD3sXhsVOhu74%3D 10.1128/JVI.77.5.3157-3166.2003 12584340
10. G Rezza V Fiorelli M Dorrucci M Ciccozzi A Tripiciano A Scoglio B Collacchi M Ruiz-Alvarez C Giannetto A Caputo L Tomasoni F Castelli M Sciandra A Sinicco F Ensoli S Butto B Ensoli 2005 The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters J Infect Dis 191 1321 1324 10.1086/428909 15776379
11. SK Arya C Guo SF Josephs F Wong-Staal 1985 Trans-activator gene of human T-lymphotropic virus type III (HTLV-III) Science 229 69 73 1:CAS:528: DyaL2MXkvF2mt78%3D 10.1126/science.2990040 2990040
12. HK Chang RC Gallo B Ensoli 1995 Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein J Biomed Sci 2 189 202 1:CAS:528:DyaK2MXotFens70%3D 10.1007/BF02253380 11725056
13. B Ensoli V Fiorelli F Ensoli A Cafaro F Titti S Butto P Monini M Magnani A Caputo E Garaci 2006 Candidate HIV-1 Tat vaccine development: from basic science to clinical trials AIDS 20 2245 2261 10.1097/QAD.0b013e3280112cd1 17117011
14. AG Fisher MB Feinberg SF Josephs ME Harper LM Marselle G Reyes MA Gonda A Aldovini C Debouk RC Gallo 1986 The trans-activator gene of HTLV-III is essential for virus replication Nature 320 367 371 1:CAS:528:DyaL28XitVWgsLw%3D 10.1038/320367a0 3007995 and
15. B Ensoli V Fiorelli F Ensoli A Lazzarin R Visintini P Narciso A Di Carlo P Monini M Magnani E Garaci 2008 The therapeutic phase I trial of the recombinant native HIV-1 Tat protein AIDS 22 2207 2209 1:CAS:528: DC%2BD1cXhtF2js77M 10.1097/QAD.0b013e32831392d4 18832884
16. O Longo A Tripiciano V Fiorelli S Bellino A Scoglio B Collacchi MJ Alvarez V Francavilla A Arancio G Paniccia A Lazzarin G Tambussi CT Din R Visintini P Narciso A Antinori G D'Offizi M Giulianelli M Carta A Di Carlo G Palamara M Giuliani ME Laguardia P Monini M Magnani F Ensoli B Ensoli 2009 Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up Vaccine 27 3306 3312 1:CAS:528:DC%2BD1MXmtlKguro%3D 10.1016/j.vaccine.2009.01.090 19208456
17. AD Frankel DS Bredt CO Pabo 1988 Tat protein from human immunodeficiency virus forms a metal-linked dimer Science 240 70 73 1:CAS:528:DyaL1cXitFOqsLg%3D 10.1126/science.2832944 2832944
18. HW Huang KT Wang 1996 Structural characterization of the metal binding site in the cysteine-rich region of HIV-1 Tat protein Biochem Biophys Res Commun 227 615 621 1:CAS:528:DyaK28Xmt1Kns7s%3D 10.1006/bbrc.1996.1554 8878561
19. G Goldstein G Tribbick K Manson 2001 Two B cell epitopes of HIV-1 Tat protein have limited antigenic polymorphism in geographically diverse HIV-1 strains Vaccine 19 1738 1746 1:CAS:528:DC%2BD3MXptVyktA%3D%3D 10.1016/S0264-410X(00)00393-5 11166899
20. G Barillari R Gendelman RC Gallo B Ensoli 1993 The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence Proc Natl Acad Sci USA 90 7941 7945 1:CAS:528:DyaK3sXmtVWlsrk%3D 10.1073/pnas.90.17.7941 7690138
21. Jeang K-T (1996) HIV-1 Tat: structure and function. In: HIV sequence compendium 1996, Part III. Theoretical Biol and Biophys Group, Los Alamos Nat Lab, pp 3-18
22. M Mishra S Vetrivel NB Siddappa U Ranga P Seth 2008 Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif Ann Neurol 63 366 376 1:CAS:528:DC%2BD1cXlt1CktLs%3D 10.1002/ana.21292 18074388
23. SE Koken AE Greijer K van Verhoef J Wamel AG Bukrinskaya B Berkhout 1994 Intracellular analysis of in vitro modified HIV Tat protein J Biol Chem 269 8366 8375 1:CAS:528:DyaK2cXktVagtb8%3D 8132560
24. E Fanales-Belasio A Cafaro A Cara DR Negri V Fiorelli S Butto S Moretti MT Maggiorella S Baroncelli Z Michelini A Tripiciano L Sernicola A Scoglio A Borsetti B Ridolfi R Bona P ten Haaft I Macchia P Leone MR Pavone-Cossut F Nappi E Vardas M Magnani E Laguardia A Caputo F Titti B Ensoli 2002 HIV-1 Tat-based vaccines: from basic science to clinical trials DNA Cell Biol 21 599 610 1:CAS:528:DC%2BD38XnsFKmtbo%3D 10.1089/104454902760330138 12396602
25. AFSA Habeeb 1972 Reaction of protein sulfhydryl groups with Ellman's reagent Methods Enzymol 25 457 464 1:CAS:528:DyaE38XltFWjtrk%3D 10.1016/S0076-6879(72)25041-8
26. LI Leichert U Jakob 2004 Protein thiol modifications visualized in vivo PLoS Biol 2 e333 10.1371/journal.pbio.0020333 15502869
27. UK Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685 1:CAS:528:DC%2BD3MXlsFags7s%3D 10.1038/227680a0 5432063
28. HK Ziegler ER Unanue 1982 Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells Proc Natl Acad Sci USA 79 175 178 1:CAS:528: DyaL38Xotl2lug%3D%3D 10.1073/pnas.79.1.175 6798568
29. NB Siddappa M Venkatramanan P Venkatesh MV Janki N Jayasuryan A Desai V Ravi U Ranga 2006 Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein Retrovirology 3 53 10.1186/1742-4690-3-53 16916472
30. E Fanales-Belasio S Moretti F Nappi G Barillari F Micheletti A Cafaro B Ensoli 2002 Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses J Immunol 168 197 206 1:CAS:528:DC%2BD38Xht1GmsA%3D%3D 11751963
31. KT Jeang H Xiao EA Rich 1999 Multifaceted activities of the HIV-1 transactivator of transcription, Tat J Biol Chem 274 28837 28840 1:CAS:528:DyaK1MXmslWqs74%3D 10.1074/jbc.274.41.28837 10506122
32. AL Fink 2005 Natively unfolded proteins Curr Opin Struct Biol 15 35 41 1:CAS:528:DC%2BD2MXhsFSht7o%3D 10.1016/j.sbi.2005.01.002 15718131
33. R Linding RB Russell V Neduva TJ Gibson 2003 GlobPlot: exploring protein sequences for globularity and disorder Nucleic Acids Res 31 3701 3708 1:CAS:528:DC%2BD3sXltVWjsLs%3D 10.1093/nar/gkg519 12824398
34. VN Uversky JR Gillespie AL Fink 2000 Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 41 415 427 1:CAS:528:DC%2BD3cXnslGnsLs%3D 10.1002/1097-0134(20001115)41:3<415:: AID-PROT130>3.0.CO;2-7 11025552
35. VN Uversky 2002 Natively unfolded proteins: a point where biology waits for physics Protein Sci 11 739 756 1:CAS:528:DC%2BD38Xis1Wmu74%3D 10.1110/ps.4210102 11910019
36. AC Vendel KJ Lumb 2003 Molecular recognition of the human coactivator CBP by the HIV-1 transcriptional activator Tat Biochemistry 42 910 916 1:CAS:528:DC%2BD3sXitVGjtQ%3D%3D 10.1021/bi0270034 12549909
37. S Shojania JD O'Neil 2006 HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy J Biol Chem 281 8347 8356 1:CAS:528:DC%2BD28XivVCgtb4%3D 10.1074/jbc.M510748200 16423825
38. AP Rice F Chan 1991 Tat protein of human immunodeficiency virus type 1 is a monomer when expressed in mammalian cells Virology 185 451 454 1:CAS:528:DyaK38XjslGksA%3D%3D 10.1016/0042-6822(91)90797-F 1656598
39. S Ruben A Perkins R Purcell K Joung R Sia R Burghoff WA Haseltine CA Rosen 1989 Structural and functional characterization of human immunodeficiency virus tat protein J Virol 63 1 8 1:CAS:528:DyaL1MXltlartg%3D%3D 2535718
40. MR Sadaie R Mukhopadhyaya ZN Benaissa GN Pavlakis F Wong-Staal 1990 Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication AIDS Res Hum Retroviruses 6 1257 1263 1:CAS:528:DyaK3MXitVeiu7Y%3D 2078407
41. TH Tahirov ND Babayeva K Varzavand JJ Cooper SC Sedore DH Price 2010 Crystal structure of HIV-1 Tat complexed with human P-TEFb Nature 465 747 751 1:CAS:528:DC%2BC3cXntF2mt78%3D 10.1038/nature09131 20535204
42. PO Falnes K Sandvig 2000 Penetration of protein toxins into cells Curr Opin Cell Biol 12 407 413 1:CAS:528:DC%2BD3cXlt1Srtb0%3D 10.1016/S0955-0674(00) 00109-5 10873820
43. LY Liou CH Herrmann AP Rice 2004 HIV-1 infection and regulation of Tat function in macrophages Int J Biochem Cell Biol 36 1767 1775 1:CAS:528:DC%2BD2cXks12qsL0%3D 10.1016/j.biocel.2004.02.018 15183343
44. E Fanales-Belasio S Moretti V Fiorelli A Tripiciano MR Pavone Cossut A Scoglio B Collacchi F Nappi I Macchia S Bellino V Francavilla A Caputo G Barillari M Magnani ME Laguardia A Cafaro F Titti P Monini F Ensoli B Ensoli 2009 HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection J Immunol 182 2888 2897 1:CAS:528:DC%2BD1MXitFKhtbY%3D 10.4049/jimmunol.0711406 19234184
45. J Kittiworakarn A Lecoq G Moine R Thai E Lajeunesse P Drevet C Vidaud A Menez M Leonetti 2006 HIV-1 Tat raises an adjuvant-free humoral immune response controlled by its core region and its ability to form cysteine-mediated oligomers J Biol Chem 281 3105 3115 1:CAS:528:DC%2BD28XhtFSnu74%3D 10.1074/jbc.M509899200 16321975